Cabozantinib and vandatinib for treating advanced or metastatic medullary thyroid cancer [ID56]
- Type of research project :
- Research project
- Funded by an IRDiRC member
- Funding body(ies) :
- NIHR - NATIONAL INSTITUTE FOR HEALTH RESEARCH
Investigator of research project
- INFORMATION NOT PROVIDED
- Institution: Information not provided - UK
- ADDRESS: NOT PROVIDED - UK NYI UK
- UNITED KINGDOM
- More information
- Phone : -
- Fax : -
Public funding body
- NIHR - NATIONAL INSTITUTE FOR HEALTH RESEARCH
- Institution: Information not provided - UK
- ADDRESS: NOT PROVIDED - UK NYI UK
- UNITED KINGDOM
- More information
- Phone : -
- Fax : -
Last update: August 2018
Additional information
Further information on this research
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.